## ACMR: ACM Research, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-7.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($33.73)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.71M) |
| Sells | 5 ($6.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Blackrock Inc.: 12.7% (+84.8%)
- Vanguard Group Inc: 8.1% (+12.8%)
- LSV Asset Management: 4.2% (+462.9%)
- Triata Capital Ltd: 3.4% (+26.0%)
- State Street Corpora: 3.3% (+58.6%)

### Key Risks

1. Insider selling cluster: $6.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Balance sheet: strong liquidity (3.5x). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.5B |
| Beta | 1.45 |
| 52W Range | $14.65 - $45.12 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 18.2 |
| Current P/E | 20.6 |
| YoY Growth | 13.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 8.7% to 1.6% (-7.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.56% (CS: 59) | Neutral |
| RSI_14 | 57.8 | Neutral |
| MACD Histogram | 0.39 | Bullish |
| vs SMA20 | 1.076x | Above |
| vs SMA50 | 1.044x | Above |
| vs SMA200 | 1.292x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $37.81
- **Stop Loss:** $33.73 (10.8% risk)
- **Target:** $41.89 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 232
- **Position Value:** $8,771.92
- **Portfolio %:** 8.77%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-25 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.36 | -32.4% |
| 2025Q2 | $0.50 | $0.54 | +7.5% |
| 2025Q1 | $0.35 | $0.46 | +32.4% |
| 2024Q4 | $0.39 | $0.56 | +44.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*